...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >A study to assess the completeness of informed consent documents for biomedical research on human participants submitted to the institutional ethics committee of a tertiary care hospital
【24h】

A study to assess the completeness of informed consent documents for biomedical research on human participants submitted to the institutional ethics committee of a tertiary care hospital

机译:评估知情同意文件的完整性,以提交第三级护理医院机构伦理委员会的人伦理委员会的生物医学研究

获取原文
           

摘要

Background: Informed consent is an essential pre-requisite for research on human participants. However, many studies have shown that informed consent documents (ICDs) are incomplete and lack many of the essential elements. The objective of the study was to assess the completeness of ICDs submitted to an institutional ethics committee (IEC) against the Indian Council of Medical Research (ICMR) ethical guidelines for biomedical research on human participants. Methods: This is a retrospective cross-sectional study. The ICDs submitted to the IEC during the period from January 2015 to December 2017 were reviewed for completeness, with the help of a checklist which is based ICMR ethical guidelines for biomedical research on human participants 2006. Results: A total of 212 ICDs were reviewed during the study period. More than 50% of the ICDs have clearly explained many of the essential elements like nature and purpose of the study (62.3%), voluntary participation (98.6%), procedures (68.9%), risks (71.2%), benefits (92.9%), alternative treatments (60.7%), maintaining confidentiality (99.1%), no loss of benefits on withdrawal from the study (87.8%) and contact details of principal investigator (99.5%). However, the other essential elements of the ICD are either not mentioned or not clearly explained. Conclusions: This study has shown that although majority of the ICDs submitted for review by the IEC have mentioned many of the essential elements, some of the elements like contact details of Chairman of IEC, future use of sample, compensation for trial related injury and provision of counseling for consent of genetics testing have not been stated.
机译:背景:知情同意是人类参与者研究的重要前提条件。然而,许多研究表明,知情同意文件(ICDS)是不完整的,缺乏许多基本要素。该研究的目的是评估对ICDS提交给机构伦理委员会(IEC)的ICDS的完整性,以防止印度医学研究委员会(ICMR)人体参与者的生物医学研究伦理准则。方法:这是回顾性横截面研究。在2015年1月至2017年12月期间提交了IEC的ICD,审查了完整性,借助核对清单是基于2006年的人为参与者的ICMR伦理研究的ICMR道德准则。结果:期间,共有212名ICDS审查研究期。 50%以上的ICD已经清楚地解释了许多基本性和目的的基本要素(62.3%),自愿参与(98.6%),程序(68.9%),风险(71.2%),福利(92.9%) ),替代治疗(60.7%),维持机密性(99.1%),从研究中撤出没有损失(87.8%)并联系主要调查员(99.5%)。但是,ICD的其他基本要素未提及或未清楚地解释。结论:这项研究表明,虽然IEC提交了大多数ICD的ICD,但有许多基本要素,一些元素,如IEC主席,未来使用样品,审判赔偿补偿和拨款尚未说明遗传检测同意的咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号